Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02905851|
Recruitment Status : Completed
First Posted : September 19, 2016
Last Update Posted : July 2, 2018
|Condition or disease||Intervention/treatment||Phase|
|Acne Vulgaris||Other: Feedback group Other: Non Feedback group||Not Applicable|
The investigators are going to ascertain if antibiotic burden can be reduced with tele dermatology use.
There are two arms of the study:
- Feedback group
- Non feedback group
All subjects will be randomised to either group, all subjects will take photos of their face and answer questions at baseline, visit 2 (1 month), visit 3 (2 months), visit 4 (3 months).
The investigators will then use measurements of acne grading (patient grading, investigator global assessment, lesion counting, global acne grading) to reduce/taper antibiotics in the feedback group.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||4 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris|
|Study Start Date :||May 2016|
|Actual Primary Completion Date :||May 2018|
|Actual Study Completion Date :||May 2018|
Placebo Comparator: Non Feedback
No feedback given to this group regarding their antibiotic use Subjects take images and answer questions during the study like the feedback group, but in this group no feedback re dosing is given.
Other: Non Feedback group
To use as control to see if antibiotic burden has been reduced in the active feedback group
Active Comparator: Feedback group
Feedback given to this group regarding their antibiotic use after baseline.
If the subject is in the feedback group, after this visit, a dermatologist will review all images and the survey results and give the patient information about whether they should:
Other: Feedback group
Monitoring ability to use teledermatology to modify antibiotic burden
- Reduced antibiotic use [ Time Frame: Assessed at 4, 8, 12 weeks ]The difference in antibiotic exposure in the physician feedback group compared to those not receiving feedback
- Change in acne grading (change in patient grading) [ Time Frame: Assessed at 4, 8, 12 weeks ]Change in Patient Grading
- Change in acne grading (investigator global assessment) [ Time Frame: Assessed at 4, 8, 12 weeks ]Change in Investigator Global Assessment
- Change in acne grading (lesion counting) [ Time Frame: Assessed at 4, 8, 12 weeks ]Change in Lesion Counting
- Change in acne grading using the global acne grading [ Time Frame: Assessed at 4, 8, 12 weeks ]Change in Global Acne Grading
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02905851
|United States, California|
|UC Davis Department of Dermatology, Clinical Trials Unit|
|Sacramento, California, United States, 95816|
|Principal Investigator:||Raja Sivamani, MD||UC Davis|